Coherus Biosciences reported $51.08M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
AbbVie USD 62.48B 2.05B Jun/2026
Acadia Pharmaceuticals USD 0 0 Mar/2025
Akebia Therapeutics USD 12.78M 11.98M Sep/2026
ALKERMES USD 1.47B 5.38M Sep/2026
Alnylam Pharmaceuticals USD 2.11B 358.58M Sep/2026
Amgen USD 51.61B 250M Sep/2026
Baxter International USD 8.62B 6M Jun/2026
Biogen USD 7.29B 1.7M Sep/2026
BioMarin Pharmaceutical USD 3.51B 12.96M Sep/2026
Bristol-Myers Squibb USD 41.85B 244M Sep/2026
Coherus Biosciences USD 51.08M 496K Dec/2025
Eli Lilly USD 46.99B 872M Sep/2026
Fujifilm JPY 598.55B 69.78B Sep/2026
Gilead Sciences USD 23.82B 17M Sep/2026
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
Merck USD 49.69B 1.39B Sep/2026
Myriad Genetics USD 120.7M 400K Jun/2026
Perrigo USD 3.28B 600K Sep/2026
Pfizer USD 60B 498M Sep/2026
PTC Therapeutics USD 536.27M 749K Sep/2026
Regeneron Pharmaceuticals USD 1.99B 400K Sep/2026
Sarepta Therapeutics USD 699.39M 148.23M Sep/2026
Teva Pharmaceutical Industries USD 12.68B 588M Sep/2026
Vertex Pharmaceuticals USD 3.5B 3.39B Sep/2026
Xencor USD 71.93M 5.61M Sep/2026
Zoetis USD 8.3B 749M Sep/2026